Literature DB >> 10362057

Severe respiratory failure requiring ICU admission in bone marrow transplant recipients.

D Gruson1, G Hilbert, L Portel, J M Boiron, C M Bebear, F Vargas, C Bebear, J Reiffers, G Gbikpi-Benissan, J P Cardinaud.   

Abstract

Two groups of bone marrow transplant (BMT) recipients with febrile noncardiogenic respiratory failure requiring intensive care unit (ICU) admission, in the early phase of bone marrow transplantation were compared: those who had proven infectious pneumonia and those in whom bronchoalveolar lavage (BAL) failed to establish a diagnosis. Thirty-eight consecutive neutropenic BMT recipients admitted to an ICU with febrile noncardiogenic respiratory failure were enrolled. All of them underwent a BAL with viral, fungal, bacterial, and histopathological examinations. Lung biopsies were performed in nonsurviving patients in order to compare with BAL results. Haematological, biological, respiratory failure and other organ failure parameters, infectious results, outcome, and lung biopsy results were evaluated. BAL allowed an infectious diagnosis to be established in 16 BMT recipients. No aetiology was proven in 22 patients. Without a significant difference in respiratory failure parameters on ICU admission, noninvasive continuous positive airway pressure ventilation, which was given to 11 patients in each group, was significantly more successful in patients with proven infectious pneumonia (6 of 11 versus 0 of 11 patients) and enabled endotracheal intubation to be avoided in significantly more patients with infectious disease (10 of 16 versus 22 of 22 patients). The evolution of patients without diagnosis was significantly different with more frequent renal failure, hepatic failure, and death (20 of 22 versus 9 of 16 patients). Post mortem biopsies confirmed the absence of micro-organisms, but endothelial damage and fibrosis was found in 14 of the 22 patients. In conclusion, in the early phase of bone marrow transplantation the recipients without proven aetiology of pneumonia have a worse outcome than grafted patients with proven infectious pneumonia.

Entities:  

Mesh:

Year:  1999        PMID: 10362057     DOI: 10.1034/j.1399-3003.1999.13d31.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

Review 1.  Diagnostic strategy in cancer patients with acute respiratory failure.

Authors:  Elie Azoulay; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2006-04-29       Impact factor: 17.440

2.  Documented and clinically suspected bacterial infection precipitating intensive care unit admission in patients with hematological malignancies: impact on outcome.

Authors:  Dominique D Benoit; Pieter O Depuydt; Renaat A Peleman; Fritz C Offner; Koenraad H Vandewoude; Dirk P Vogelaers; Stijn I Blot; Lucien A Noens; Francis A Colardyn; Johan M Decruyenaere
Journal:  Intensive Care Med       Date:  2005-03-22       Impact factor: 17.440

3.  Predictive factors of intensive care unit admission in patients with haematological malignancies and pneumonia.

Authors:  Didier Gruson; Frederic Vargas; Gilles Hilbert; Nam Bui; Thierry Maillot; Thierry Mayet; Odile Pillet; Genevieve Chene; Georges Gbikpi-Benissan
Journal:  Intensive Care Med       Date:  2004-03-30       Impact factor: 17.440

4.  Use of N-terminal pro-brain natriuretic peptide to detect cardiac origin in critically ill cancer patients with acute respiratory failure.

Authors:  Aurélie Lefebvre; Suzanne Kural-Menasché; Michael Darmon; Guillaume Thiéry; Jean-Paul Feugeas; Benoît Schlemmer; Elie Azoulay
Journal:  Intensive Care Med       Date:  2008-01-24       Impact factor: 17.440

5.  Efficacy and tolerability of non-invasive ventilation delivered via a newly developed helmet in immunosuppressed patients with acute respiratory failure.

Authors:  Werner Rabitsch; Peter Schellongowski; Wolfgang J Köstler; Brigitte Stoiser; Paul Knöbl; Gottfried J Locker; Wolfgang Sperr; Heinz Burgmann; Harald Herkner; Felix Keil; Michael Frass; Thomas Staudinger
Journal:  Wien Klin Wochenschr       Date:  2003-09-15       Impact factor: 1.704

6.  Impact of organ dysfunction on mortality in ICU patients with hematologic malignancies.

Authors:  Dominique M Vandijck; Pieter O Depuydt; Fritz C Offner; Joke Nollet; Renaat A Peleman; Eva Steel; Lucien A Noens; Johan M Decruyenaere; Dominique D Benoit
Journal:  Intensive Care Med       Date:  2010-05-18       Impact factor: 17.440

7.  Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancy.

Authors:  Vincenzo Squadrone; Massimo Massaia; Benedetto Bruno; Filippo Marmont; Michele Falda; Carlotta Bagna; Stefania Bertone; Claudia Filippini; Arthur S Slutsky; Umberto Vitolo; Mario Boccadoro; V Marco Ranieri
Journal:  Intensive Care Med       Date:  2010-06-09       Impact factor: 17.440

8.  The strategy of antibiotic use in critically ill neutropenic patients.

Authors:  Matthieu Legrand; Adeline Max; Benoît Schlemmer; Elie Azoulay; Bertrand Gachot
Journal:  Ann Intensive Care       Date:  2011-06-15       Impact factor: 6.925

9. 

Authors:  L Camous; V Lemiale; D Schnell; S de Miranda; E Azoulay
Journal:  Rev Malad Respir Actual       Date:  2010-04-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.